Développement de deux instruments LIDAR multi-longueurs d'onde et multi-espèces à base de sources paramétriques

Atmospheric global monitoring and air quality are major environmental concerns. Global monitoring of some trace and green-house gases would help to understand the consequences of human activities on our environment. The aim of this work is to develop two multi-wavelengths and multi-species direct detection lidar instruments, based on the same laser transmitter baseline approach - an innovative parametric source, the Nested Cavity optical parametric oscilator-and to target two applications: the monitoring of air quality on industrial sites and the monitoring of greenhouse gases from space. The first instrument was designed for industrial plant monitoring applications, in the 3.3-3.8µm, and allows the measurement of multi-species mean concentrations along the line of sight, over a range of around a hundred meters. This instrument was implemented for simultaneous measurements of atmospheric methane and water vapour.The second instrument targets the green-house gases measurement from space applications. In this frame, a new multi-wavelengths and multi-species emitter was developed at 2 µm for space applications. We have demonstrated that this new emitter could address three species: carbon dioxide, water vapor and methane, and studied his potential for space-borne applications.. The architecture of a complete range-resolved instrument based on this transmitter was proposed. Moreover, a numerical algorithm was developed to estimate the instrument’s performances with a direct detection scheme.La surveillance globale de l’atmosphère et de la pollution de l’air est devenue un enjeu majeur ces dernières années afin d’estimer les conséquences des activités humaines sur notre environnement. Au cours de ces travaux de thèse, l’objectif a été de développer deux instruments LIDARs en détection directe basés sur des émetteurs multi-longueurs d’onde et multi-espèces mettant en œuvre des sources paramétriques optiques innovantes basées sur la technologie NesCOPO (nested cavity optical parametric oscillator) afin de répondre à deux applications : le suivi de la qualité de l’air sur sites industriels et le suivi des gaz à effet de serre depuis l’espace. Un premier instrument multi-espèces a été développé dans le cadre du suivi de la qualité de l’air sur sites industriels, dans la gamme spectrale 3,3 à 3,8 µm, et dédié à des mesures de concentrations moyennes le long de la ligne de visée pour des portées de l’ordre de la centaine de mètres. Une démonstration du potentiel multi-espèces de l’instrument a été réalisée en mesurant simultanément les concentrations en méthane et en vapeur d’eau atmosphériques. A partir d’une source optique existante dédiée à la mesure du dioxyde de carbone seul, un second émetteur multi-longueurs d’onde et multi-espèces a été développé dans une gamme spectrale autour de 2 µm. Son potentiel pour la mesure des gaz à effets de serre depuis l’espace a été étudié En particulier, nous avons démontré que cet émetteur permet de mesurer trois gaz atmosphériques : CO2, H2O et CH4. Une architecture globale d’instrument intégrant cet émetteur a été proposée, afin de réaliser des mesures résolues spatialement, avec des portées de quelques km. De plus, un code de simulation a été développé pour estimer les performances de cet instrument en détection directe

Une jeunesse en "stand by": parcours de vie et vécu de huit jeunes adultes bénéficiaires de l'aide sociale à Genève : travail de Bachelor effectué dans le cadre de la formation à la Haute école de travail social de Genève

Cette recherche tente de répondre à ces deux questions à travers l’analyse du discours de jeunes adultes au bénéfice de l’aide sociale. Qui sont ces jeunes ? Comment appréhendent-ils leur situation ? Curieux de mieux connaître cette population au parcours tortueux, nous avons voulu les rencontrer. Nous avons donné la parole à ces personnes et non pas à ceux qui parlent d’elles. Pour ce faire, nous avons interviewé huit jeunes adultes qui ont accepté de livrer une partie de leur vécu. Cette recherche s’organise autour d’un cadre théorique et de matériel empirique dont ces entretiens constituent la partie essentielle

Mental Health Outcomes at a Student-Run Free Clinic

In this project we aim to: 1. Assess the outcomes of screening, management, and diagnosis for patients at the Rowan Community Health Center (RCHC). 2. Compare the outcomes of screening, management, and diagnosis between different groups (gender, race, income, insurance status) using validated surveys. 3. There is a need for accessible and affordable primary care in the South Jersey area, which the RCHC is hoping to meet. Hypothesis: The quality of mental health care available to patients at the RCHC is comparable to that at other insured practices

COVID-19 at a Glance: An Up-to-Date Overview on Variants, Drug Design and Therapies

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a member of the Coronavirus family which caused the worldwide pandemic of human respiratory illness coronavirus disease 2019 (COVID-19). Presumably emerging at the end of 2019, it poses a severe threat to public health and safety, with a high incidence of transmission, predominately through aerosols and/or direct contact with infected surfaces. In 2020, the search for vaccines began, leading to the obtaining of, to date, about twenty COVID-19 vaccines approved for use in at least one country. However, COVID-19 continues to spread and new genetic mutations and variants have been discovered, requiring pharmacological treatments. The most common therapies for COVID-19 are represented by antiviral and antimalarial agents, antibiotics, immunomodulators, angiotensin II receptor blockers, bradykinin B2 receptor antagonists and corticosteroids. In addition, nutraceuticals, vitamins D and C, omega-3 fatty acids and probiotics are under study. Finally, drug repositioning, which concerns the investigation of existing drugs for new therapeutic target indications, has been widely proposed in the literature for COVID-19 therapies. Considering the importance of this ongoing global public health emergency, this review aims to offer a synthetic up-to-date overview regarding diagnoses, variants and vaccines for COVID-19, with particular attention paid to the adopted treatments

Impact of Cytochrome P450 Enzymes on the Phase I Metabolism of Drugs

The cytochrome P450 (CYP) enzyme family is the major enzyme system catalyzing the phase I metabolism of xenobiotics, including pharmaceuticals and toxic compounds in the environment. A major part of the CYP-dependent xenobiotic metabolism is due to polymorphic and inducible enzymes, which may, quantitatively or qualitatively, alter or enhance drug metabolism and toxicity. Drug–drug interactions are major mechanisms caused by the inhibition and/or induction of CYP enzymes. Particularly, CYP monooxygenases catalyze hydroxylation reactions to form hydroxylated metabolites. The secondary metabolites are sometimes as active as the parent compound, or even more active. The aim of this review is to summarize some of the significative examples of common drugs used for the treatment of diverse diseases and underline the activity and/or toxicity of their metabolites

Triclosan: A Small Molecule with Controversial Roles

Abstract: Triclosan (TCS), a broad-spectrum antimicrobial agent, has been widely used in personal care products, medical products, plastic cutting boards, and food storage containers. Colgate Total® toothpaste, containing 10 mM TCS, is effective in controlling biofilm formation and maintaining gingival health. Given its broad usage, TCS is present ubiquitously in the environment. Given its strong lipophilicity and accumulation ability in organisms, it is potentially harmful to biohealth. Several reports suggest the toxicity of this compound, which is inserted in the class of endocrine disrupting chemicals (EDCs). In September 2016, TCS was banned by the U.S. Food and Drug Administration (FDA) and the European Union in soap products. Despite these problems, its application in personal care products within certain limits is still allowed. Today, it is still unclear whether TCS is truly toxic to mammals and the adverse effects of continuous, long-term, and low concentration exposure remain unknown. Indeed, some recent reports suggest the use of TCS as a repositioned drug for cancer treatment and cutaneous leishmaniasis. In this scenario it is necessary to investigate the advantages and disadvantages of TCS, to understand whether its use is advisable or not. This review intends to highlight the pros and cons that are associated with the use of TCS in humans

Synthesis of Novel N-Heterocyclic Carbene-Ruthenium (II) Complexes, “Precious” Tools with Antibacterial, Anticancer and Antioxidant Properties

Ruthenium N-heterocyclic carbene (Ru-NHC) complexes show interesting physico-chemical properties as catalysts and potential in medicinal chemistry, exhibiting multiple biological activities, among them anticancer, antimicrobial, antioxidant, and anti-inflammatory. Herein, we designed and synthesized a new series of Ru-NHC complexes and evaluated their biological activities as anticancer, antibacterial, and antioxidant agents. Among the newly synthesized complexes, RANHC-V and RANHC-VI are the most active against triple-negative human breast cancer cell lines MDA-MB-231. These compounds were selective in vitro inhibitors of the human topoisomerase I activity and triggered cell death by apoptosis. Furthermore, the Ru-NHC complexes’ antimicrobial activity was studied against Gram-positive and -negative bacteria, revealing that all the complexes possessed the best antibacterial activity against the Gram-positive Staphylococcus aureus, at a concentration of 25 µg/mL. Finally, the antioxidant effect was assessed by DPPH and ABTS radicals scavenging assays, resulting in a higher ability for inhibiting the ABTS•+, with respect to the well-known antioxidant Trolox. Thus, this work provides encouraging insights for further development of novel Ru-NHC complexes as potent chemotherapeutic agents endowed with multiple biological properties. © 2023 by the authors

The Need for Depression and Anxiety Screenings at a Student-Run Clinic

General anxiety and major depressive disorder are common and treatable mental health disorders. The US Preventive Services Task Force provides strong evidence that early screening helps identify depression in primary care settings, promotes intervention and facilitates treatment. Many medical offices use validated screening tools, GAD-7 and PHQ-9, to measure symptom severities and further help guide treatment modalities for patients with anxiety and depression, respectively. The Rowan Community Health Clinic (RCHC) in Lindenwold, NJ is a student-run free clinic that serves patients regardless of patient gender, race, income, or insurance status. This study aims to determine if there is a need to build internal infrastructure at RCHC for depression and anxiety management. This study started in June 2021 and had a total of 25 patients. Patients were administered both the GAD-7 and PHQ-9 for screening and were given various resources and/or referrals depending on their calculated score. Data was stored in Qualtrics and analyzed in SPSS. While this study had a small sample size, it was evident that both anxiety and depression play a role in our patients’ lives despite not seeing any significant data between minimal and moderate-to-severe depression and/or anxiety. With these tools only being able to measure symptom severity, further psychiatric evaluation is also essential to accurately diagnose mental health disorders. Future steps involve increasing sample size as well as comparing data with insured patients at a Family Medicine office. One of RCHC’s goals is to use our preliminary data in order to start a framework and provide accessible mental health services within our student-run clinic

Sex and Race Disparities in Mortality and Years of Potential Life Lost Among People With HIV: A 21-Year Observational Cohort Study

BACKGROUND: Since the availability of antiretroviral therapy, mortality rates among people with HIV (PWH) have decreased; however, this does not quantify premature deaths among PWH, and disparities persist. METHODS: We examined all-cause and premature mortality among PWH receiving care at the Vanderbilt Comprehensive Care Clinic from January 1998 to December 2018. Mortality rates were compared by demographic and clinical factors, and adjusted incidence rate ratios (aIRRs) were calculated using multivariable Poisson regression. For individuals who died, age-adjusted years of potential life lost (aYPLL) per total person-years living with HIV were calculated from US sex-specific life tables, and sex and race differences were examined using multivariable linear regression. RESULTS: Among 6531 individuals (51% non-Hispanic [NH] White race, 40% NH Black race, 21% cis-gender women, 78% cis-gender men) included, 956 (14.6%) died. In adjusted analysis, PWH alive in the most recent calendar era (2014-2018) had decreased risk of mortality compared with those in the earliest calendar era (1998-2003; aIRR, 0.22; 95% CI, 0.17-0.29), and women had increased risk of death compared with men (aIRR, 1.31; 95% CI, 1.12-1.54). Of those who died, Black women had the highest aYPLL (aIRR, 592.5; 95% CI, 588.4-596.6), followed by Black men (aIRR, 470.7; 95% CI, 468.4-472.9), White women (aIRR, 411.5; 95% CI, 405.6-417.4), then White men (aIRR, 308.6; 95% CI, 308.0-309.2). In adjusted models, higher YPLL remained associated with NH Black race and cis-gender women, regardless of HIV risk factor. CONCLUSIONS: Despite marked improvement over time, sex disparities in mortality as well as sex and race disparities in YPLL remained among PWH in this cohort